---
title: "Azora Therapeutics tumbles 18% during regular trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303759231.md"
description: "Azora Therapeutics fell 18.03% to US$4.000. Up 160.71% over six months and down 27.00% YTD."
datetime: "2026-10-30T13:44:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303759231.md)
  - [en](https://longbridge.com/en/news/303759231.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303759231.md)
generator: "portal-rs"
---

# Azora Therapeutics tumbles 18% during regular trading

Azora Therapeutics (AZR.US) tumbled more than **18%** during regular trading to **$4.00**.

The stock is up 160.71% over the past six months and down 27.00% year to date. It sits 56.63% below its 52-week high of US$9.223. The intraday swing reached 14.24%.

The Nasdaq Composite is down 1.47% over the past five sessions and up 10.04% year to date.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [AZR.US](https://longbridge.com/en/quote/AZR.US.md)

## Related News & Research

- [Adial Pharmaceuticals Files Initial Beneficial Ownership Statement for CFO Vassiliki Economides](https://longbridge.com/en/news/303813186.md)
- [INSTANT VIEW-Nvidia earnings beat estimates; attention turns to call](https://longbridge.com/en/news/305875718.md)
- [Will Upper Stage Recovery Change SpaceX's (SPCX) Narrative](https://longbridge.com/en/news/305914563.md)
- [Lumentum President and CEO Michael E. Hurlston Reports Disposal of $4.48 Million in Common Shares](https://longbridge.com/en/news/305879399.md)
- [Sandisk (SNDK) Stock Could Be 42% Below Fair Value Following Data Center Regulation Fears](https://longbridge.com/en/news/305917622.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**